During the past decade, Doheny Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doheny Eye Institute" #1 sponsor was "Boston Image Reading Center" with 2 trials, followed by "Lux Biosciences, Inc." with 2 trials sponsored, "National Eye Institute (NEI)" with 2 trials sponsored, "Second Sight Medical Products" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doheny Eye Institute" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Alcon Research" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Doheny Eye Institute" are "Macular Degeneration" (3 trials), "Diabetic Macular Edema" (2 trials), "Dry Macular Degeneration" (2 trials), "Ocular Hypertension" (2 trials) and "Retinitis Pigmentosa" (2 trials). Many other conditions were trialed in "Doheny Eye Institute" in a lesser frequency.

Most popular intervention types in "Doheny Eye Institute" are "Drug" (12 trials), "Device" (5 trials), "Other" (3 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "LX201" (2 trials), "SS-OCT imaging" (2 trials), "1mg triamcinolone acetonide" (1 trials) and "4mg triamcinolone acetonide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Doheny Eye Institute" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Doheny Eye Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Doheny Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Doheny Eye Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".